three
differ
method
compar
etcienc
detect
adenovirus
sampl
examin
viral
analysi
consist
concentr
prepar
raw
sewag
chosen
provid
represent
spectrum
virus
intestin
shed
larg
popul
given
time
use
one
singl
cell
line
overal
number
adenovirus
detect
use
cytopathogen
immunofluoresc
roughli
equal
situ
hybrid
approx
sensit
either
method
determin
averag
viru
titer
differ
sampl
also
prove
better
mean
nonparametr
comparison
cell
line
approx
time
sensit
detect
adenovirus
cytopathogen
compar
cell
line
prove
unsuit
hand
quantit
detect
indigen
adenovirus
immunofluoresc
rel
number
indigen
adenovirus
present
sewag
concentr
examin
averag
greater
enterovirus
assay
enterovirus
perform
plaqu
assay
bgm
cell
line
adenovirus
caus
agent
number
human
viral
ill
among
pharyng
conjunct
pharyngoconjunctiv
fever
strau
gastroenter
albert
natur
gastroenter
reason
adenovir
agent
syndrom
found
associ
fecal
materi
infecti
state
also
possibl
adenovirus
associ
syndrom
likewis
present
human
intestin
tract
result
drainag
site
infect
group
adenovirus
shown
reason
resist
low
ph
condit
field
metcalf
thu
virus
associ
ailment
may
similarli
infecti
state
time
shed
intestin
tract
object
present
studi
compar
differ
method
detect
intestin
shed
adenovirus
chose
evalu
two
rapid
assay
techniqu
first
indirect
immunofluoresc
method
second
situ
dna
probe
hybrid
approach
util
biotinavidin
system
conjunct
author
correspond
address
telephon
number
tpresent
address
nation
cancer
institut
nation
institut
health
bethesda
md
usa
horseradish
peroxidas
techniqu
incorpor
incub
period
h
time
cell
cultur
infect
time
cultur
subsequ
fix
stain
examin
rapid
approach
result
format
focal
area
viral
infect
visual
enumer
microscop
examin
two
method
contrast
tradit
approach
isol
adenovirus
cell
cultur
determin
product
characterist
cytopathogen
effect
approach
hand
requir
incub
period
day
obtain
complet
result
sampl
examin
studi
presenc
virus
consist
concentr
produc
raw
sewag
approach
chosen
reflect
overal
sampl
popul
virus
shed
member
commun
sellwood
et
al
cell
line
use
studi
bgm
continu
line
origin
african
green
monkey
kidney
continu
human
epidermoid
carcinoma
line
transform
primari
human
embryon
kidney
line
bgm
cell
line
obtain
daniel
r
dahl
us
epa
cincinnati
ohio
cell
line
purchas
american
type
cultur
collect
rockvil
md
product
individu
bgm
cultur
perform
viral
plaqu
titrat
assay
done
cm
tissu
cultur
flask
product
tube
cultur
either
cell
use
cytopathogen
assay
done
screwcap
x
mm
cultur
tube
type
tube
materi
use
cytopathogen
assay
depend
upon
cell
line
borosil
glass
cell
polystyren
line
choic
latter
combin
base
upon
find
cell
line
grow
well
glass
surfac
product
individu
cell
cultur
either
immunofluoresc
situ
hybrid
assay
done
use
chamber
slide
remov
gasket
labtek
mile
laboratori
inc
napervil
ill
medium
use
routin
cultiv
bgm
cell
line
consist
equal
part
eagl
minimum
essenti
medium
mem
leibovitz
medium
supplement
vv
fetal
bovin
serum
fb
ml
wv
stock
sodium
bicarbon
solut
medium
also
use
prepar
individu
flask
cultur
bgm
cell
use
viru
plaqu
assay
medium
use
routin
cultiv
cell
line
prepar
tube
cultur
line
consist
mem
supplement
vv
fb
ml
sodium
bicarbon
solut
medium
use
cultiv
cell
line
chamber
slide
list
except
incorpor
sodium
bicarbon
solut
lower
level
ml
medium
use
routin
cultiv
cell
line
prepar
tube
cultur
line
consist
mem
supplement
vv
fb
ml
sodium
bicarbon
solut
cultur
media
use
studi
supplement
hepe
buffer
level
mm
penicillin
g
unit
mlt
amikacin
sulfat
ug
ml
streptomycin
sulfat
g
ml
indic
guanidin
hydrochlorid
present
cultur
media
final
concentr
g
ml
order
select
suppress
replic
enterovirus
allow
unrestrict
replic
adenovirus
hurst
et
al
sewag
concentr
examin
studi
prepar
separ
vol
raw
sewag
ten
sewag
sampl
collect
period
midnovemb
middecemb
municip
treatment
facil
serv
cincinnati
ohio
area
follow
collect
sewag
sampl
adjust
final
concentr
mgci
addit
mgci
stock
solut
sampl
store
overnight
allow
solid
settl
follow
approx
onehalf
supernat
volum
sampl
decant
discard
remaind
sampl
centrifug
aliquot
min
order
pellet
solid
pellet
solid
paricular
sampl
combin
resuspend
approx
ml
phosphat
buffer
salin
contain
fb
vv
resuspend
solid
sampl
next
extract
equal
volum
cold
trifluoroethan
freon
tf
provid
e
dupont
de
nemour
co
wilmington
del
centrifug
low
speed
separ
two
phase
use
procedur
describ
hurst
goyk
upper
aqueou
phase
extract
next
centrifug
remov
residu
suspend
solid
sampl
supernat
last
g
centrifug
step
adjust
addit
beef
extract
beef
extract
purchas
powder
form
beef
extract
v
bbl
microbiolog
system
cockeysvil
md
final
concentr
wv
subject
concentr
organ
floccul
ph
describ
hurst
et
al
also
sewag
sampl
small
amount
residu
suspend
solid
present
upper
phase
follow
freon
tf
extract
elut
mix
ml
vol
buffer
beef
extract
solut
berman
et
al
follow
centrifug
rain
g
repellet
solid
filtrat
result
supernat
eluat
posit
pressur
pore
size
gelman
filter
gelman
ann
arbor
mich
order
yield
final
concentr
sampl
repres
initi
sewag
sampl
materi
produc
organ
floccul
freon
tf
extract
supernat
sewag
sampl
combin
correspond
eluat
prepar
residu
solid
final
volum
materi
assay
repres
initi
sewag
sampl
rang
ml
repres
overal
concentr
factor
approx
virus
mention
studi
indigen
sewag
concentr
titrat
adenovirus
cytopathogen
done
inocul
sampl
materi
confluent
tube
cultur
cell
line
line
found
suitabl
detect
adenovirus
techniqu
benton
ward
de
jong
et
al
takiff
et
al
tube
cultur
prepar
use
stationari
rack
one
hour
prior
inocul
sampl
materi
medium
tube
substitut
fbsfree
mem
contain
ml
sodium
bicarbon
solut
also
guanidin
hydrochlorid
refer
inocul
medium
cultur
incub
medium
interven
period
h
inocul
ml
sewag
concentr
either
prepar
follow
dilut
rate
inocul
medium
h
post
inocul
medium
tube
chang
fresh
inocul
medium
tube
return
incub
medium
addit
chang
day
post
inocul
flesh
inocul
medium
contain
chicken
serum
final
concentr
vv
cell
cultur
examin
day
post
inocul
presenc
characterist
adenovir
cytopathogen
effect
cultur
tube
contain
cell
incub
roller
apparatu
eight
day
post
inocul
period
effort
speed
develop
cytopathogen
effect
schmidt
cultur
tube
contain
cell
incub
stationari
posit
postinocul
tendenc
detach
cultur
surfac
continu
turn
viral
titer
type
assay
normal
express
term
tissu
cultur
infecti
dose
endpoint
per
ml
determin
techniqu
reed
muench
order
arriv
titrat
endpoint
could
close
compar
viral
assay
use
studi
deriv
titer
valu
divid
factor
express
tcid
mll
detect
adenovirus
either
indirect
immunofluoresc
situ
hybrid
done
use
confluent
cell
cultur
contain
chamber
slide
cell
cultur
reach
confluenc
preincub
inocul
medium
period
h
c
preincub
medium
pour
chamber
replac
ml
vol
per
well
sewag
concentr
either
prepar
follow
dilut
rate
inocul
medium
inoculum
allow
incub
place
slide
period
h
c
inoculum
replac
flesh
inocul
medium
slide
return
c
incub
addit
h
medium
contain
well
chang
fresh
inocul
medium
h
post
infect
averag
cv
valu
titer
express
term
infecti
unit
tcid
cytopathogen
flu
immunoltuoresc
situ
hybrid
ml
concentr
valu
given
repres
mean
independ
conduct
trial
sd
rang
trial
valu
tcv
coeffici
variat
averag
valu
repres
mean
separ
cv
valu
calcul
differ
sampl
fix
infect
slide
done
first
remov
medium
well
remov
chamber
slide
slide
immers
either
methanol
min
examin
immunofluoresc
carnoy
b
fix
vol
absolut
ethanol
chloroform
acet
acid
min
examin
situ
hybrid
gasket
remov
slide
follow
fixat
cell
stain
infect
cell
present
slide
examin
immunofluoresc
accomplish
use
antiserum
prepar
rabbit
antiserum
prepar
refer
reagent
nation
institut
health
purchas
american
type
cultur
collect
rockvil
md
antiserum
prepar
whole
human
adenoviru
virion
therefor
reactiv
group
common
human
adenovir
antigen
immunofluoresc
slide
wash
pb
incub
h
c
fluoresceinconjug
staphlococc
protein
dilut
pb
final
step
stain
immunofluoresc
examin
consist
wash
slide
pb
immers
evan
blue
dye
prepar
potassium
chlorid
min
rins
pb
slide
examin
enumer
fluores
cell
foci
use
epiillumin
cell
determin
posit
immunofluoresc
immedi
subject
confirm
posit
statu
morpholog
examin
use
phase
contrast
microscopi
cell
fail
recogn
posit
immunofluoresc
reactiv
well
morpholog
appear
view
phase
contrast
consid
neg
includ
determin
viru
titer
result
assay
express
term
focu
form
unit
flu
viru
per
ml
inoculum
stain
infect
cell
present
slide
examin
situ
hybrid
techniqu
accomplish
first
incub
cell
monolay
probe
solut
contain
whole
human
adenoviru
genom
dna
label
biotinlink
deoxyuridin
follow
incub
probe
solut
slide
incub
avidinhorseradish
peroxidas
conjug
follow
incub
diaminobenzidin
hydrochlorid
hydrogen
peroxid
yield
brown
precipit
posit
infect
cell
slide
counterstain
mount
coverslip
use
wv
solut
trypan
blue
naci
examin
slide
presenc
focal
area
infect
cell
accomplish
use
transmit
bright
light
microscopi
result
assay
express
term
flu
viru
per
ml
inoculum
examin
sewag
concentr
presenc
enterovirus
done
agar
overlay
plaqu
assay
techniqu
use
cultur
bgm
cell
contain
cm
tissu
cultur
flask
bgm
cell
line
recommend
sensit
purpos
dahl
wright
procedur
media
use
assay
describ
previous
benton
hurst
media
use
enteroviru
assay
specif
contain
guanidin
hydrochlorid
result
assay
express
term
plaqu
form
unit
pfu
viru
per
mt
inoculum
first
part
studi
consist
compar
sensit
cytopathogen
immunofluoresc
situ
hybrid
adenoviru
detect
make
evalu
consid
import
cell
line
use
three
detect
method
avoid
possibl
cell
linedepend
differ
viral
sensit
cell
line
chosen
comparison
difficulti
experienc
attempt
use
line
adenoviru
immunofluoresc
foci
assay
difficulti
line
firstli
tendenc
cell
roundup
sever
cours
adenovir
infect
posit
statu
fluoresc
cell
confirm
examin
cell
intern
morpholog
secondli
poor
adher
cultur
cell
line
either
glass
plastic
microscop
slide
produc
monolay
readili
detach
effort
fixat
prior
immunofluoresc
stain
result
compar
three
differ
detect
method
quantit
adenovirus
present
process
sewag
concentr
present
tabl
seen
viral
titer
yield
cytopathogen
immunofluoresc
method
overal
approxim
total
total
total
comparison
made
mean
valu
sampleassay
techniqu
combin
present
tabl
particular
sampl
method
yield
highest
assay
titer
assign
numer
valu
second
highest
assign
numer
valu
lowest
assign
numer
valu
equival
titer
yield
situ
hybrid
techniqu
case
much
higher
obtain
either
cytopathogen
immunofluoresc
although
accur
rough
estim
averag
titer
adenovirus
detect
situ
hybrid
approx
greater
base
upon
valu
averag
mean
either
two
method
reproduc
three
detect
method
approxim
equival
seen
compar
respect
valu
averag
coeffici
variat
cv
list
tabl
use
nonparametr
method
analysi
order
rank
rel
sensit
three
differ
detect
techniqu
result
analysi
present
tabl
approach
detect
method
yield
highest
assay
titer
given
sewag
concentr
assign
numer
valu
three
method
yield
second
highest
assay
titer
concentr
assign
valu
two
method
yield
lowest
assay
titer
assign
valu
overal
situ
hybrid
assay
method
best
sampl
cytopathogen
immunofluoresc
better
sampl
correspondingli
seen
result
situ
hybrid
techniqu
highest
total
score
possibl
maximum
cytopathogen
immunofluoresc
assay
techniqu
total
score
valu
approxim
equival
respect
result
assay
process
sewag
concentr
adenovirus
cytopathogen
use
cell
line
present
tabl
tabl
also
present
result
titrat
sewag
sampl
concentr
enterovirus
mean
plaqu
assay
techniqu
use
bgm
cell
line
compar
viral
assay
result
shown
tabl
express
averag
mean
adenovirus
averag
valu
enterovirus
estim
number
adenovirus
detect
process
sewag
concentr
greater
enterovirus
averag
factor
approx
compar
inform
present
tabl
seen
number
infecti
adenovirus
detect
cytopathogen
use
cell
line
approx
greater
could
detect
cytopathogen
use
cell
approxim
one
third
adenoviru
posit
cell
cultur
subject
confirm
posit
statu
indirect
immunofluoresc
util
line
procedur
confirm
consist
first
subject
cell
present
posit
cultur
tube
three
freezethaw
cycl
overli
fluid
content
posit
tube
inocul
separ
undilut
dilut
inocul
medium
onto
monolay
cul
averag
cv
valu
valu
express
term
pfu
ml
repres
result
singl
trial
calcul
standard
deviat
rang
averag
cv
would
meaning
tvalu
express
term
tcid
ml
indic
mean
independ
conduct
trial
sd
rang
trial
valu
cv
coeffici
variat
averag
valu
repres
mean
separ
cv
valu
calcul
differ
sampl
ture
cell
grown
chamber
slide
procedur
use
inocul
well
subsequ
fixat
infect
cell
methanol
stain
examin
indirect
immunofluoresc
describ
materi
method
directli
assay
sewag
concentr
cell
line
adenoviru
posit
cultur
tube
cell
examin
part
confirm
subsequ
found
posit
immunofluoresc
cell
indic
much
higher
viral
titer
obtain
perform
cytopathogen
assay
cell
line
inde
reflect
number
viabl
adenovirus
capabl
initi
replic
cell
virus
howev
capabl
subsequ
replic
cell
line
follow
first
passag
cell
suggest
effort
takiff
cowork
differ
adenovir
titer
yield
cytopathogen
cell
vs
cell
reflect
portion
total
adenoviru
popul
enter
natur
ie
serotyp
caus
agent
human
gastroenter
variabl
associ
detect
adenovirus
cytopathogen
use
cell
line
greater
hand
tabl
detect
adenovirus
either
three
techniqu
use
cell
find
obtain
compar
techniqu
cytopathogen
immunofluoresc
situ
hybrid
detect
adenovirus
interest
base
upon
identifi
differ
viral
effect
procedur
produc
posit
result
cytopathogen
necessit
product
progeni
virion
fulli
infecti
cell
cultur
line
inocul
reason
assum
necess
full
viru
replic
cytopathogen
assay
rel
low
number
viral
unit
would
present
enddilut
sewag
concentr
examin
like
far
fewer
would
need
initi
infect
cell
cultur
addit
nearli
posit
tube
reach
point
cell
demonstr
cytopath
effect
immunofluoresc
assay
requir
virus
capabl
proceed
replic
cycl
stage
produc
progeni
capsid
protein
similar
result
two
assay
techniqu
would
suggest
averag
virion
capabl
produc
capsid
protein
within
h
subsequ
abl
progress
replic
cycl
stage
assembl
fulli
infecti
progeni
given
addit
day
incub
discoveri
number
virus
detect
situ
hybrid
greater
found
use
immunofluoresc
may
suggest
member
adenoviru
popul
contain
sampl
capabl
progress
stage
gener
progeni
dna
within
h
howev
unabl
progress
significantli
given
constraint
cell
line
allow
amount
incub
time
studi
adenovir
cytopathogen
effect
gener
appear
day
post
inocul
experi
could
carri
longer
day
progress
chang
health
cell
monolay
chang
appar
associ
presenc
guanidin
hydrochlorid
cultur
media
case
cytopathogen
assay
guanidin
also
seem
make
cell
somewhat
sensit
cytotox
effect
compound
present
sewag
concentr
along
virus
hurst
goyk
increas
sensit
cytotox
result
suppress
viral
titer
undilut
sewag
concentr
gener
problem
studi
high
number
adenovirus
present
process
sewag
concentr
necessit
dilut
factor
least
prior
inocul
type
assay
chang
cell
appear
caus
guanidin
appear
problem
immunofluoresc
situ
hybrid
assay
larg
differ
number
adenovirus
detect
cytopathogen
use
line
versu
line
extent
surpris
retrospect
need
line
consid
sensit
recoveri
enter
adenovirus
serotyp
compar
line
takiff
et
al
base
upon
distinct
takiff
cowork
differ
cytopathogen
titer
observ
two
cell
line
may
repres
virus
serotyp
use
distinct
might
seem
constitut
harsh
dicotomi
would
suggest
total
popul
infecti
adenovirus
intestin
shed
member
commun
therefor
present
raw
sewag
sampl
approx
enter
natur
adenovirus
natur
present
sewag
greater
number
enterovirus
shown
true
studi
irv
smith
krike
et
al
confirm
result
find
averag
number
adenovirus
present
sewag
concentr
measur
cytopathogen
use
cell
line
greater
enterovirus
determin
plaqu
assay
contrast
find
investig
report
differ
approx
less
find
could
associ
three
possibl
factor
firstli
adenovirus
might
recov
effici
elut
concentr
procedur
use
studi
enterovirus
possibl
begun
explor
laboratori
secondli
collect
sampl
use
studi
may
coincid
peak
period
presenc
adenovirus
simultan
minimum
period
presenc
enterovirus
could
well
sampl
collect
time
period
novemberdecemb
krike
cowork
note
studi
enteroviru
titer
peak
august
septemb
expect
northern
hemispher
titer
adenovirus
peak
month
april
june
studi
group
preval
adenovir
gastroenter
northern
hemispher
would
indic
ill
two
annual
peak
one
occur
novemb
april
may
cevenini
et
al
cusi
et
al
isaac
et
al
payn
et
al
thirdli
believ
larg
differ
number
adenovirus
vs
enterovirus
detect
present
studi
also
attribut
part
use
cell
line
sensit
adenoviru
detect
use
studi
irv
smith
krike
et
al
clearli
util
guanidin
media
addit
suppress
replic
indigen
enterovirus
also
benefit
abl
detect
adenovirus
without
use
either
guanidin
similar
compound
capabl
select
suppress
replic
enterovirus
assay
titer
obtain
adenovirus
studi
similar
might
artifici
low
due
rapid
overgrowth
cell
cultur
enterovirus
overgrowth
effect
previous
even
appar
us
perform
rapid
assay
techniqu
sampl
inocul
lower
dilut
due
time
constraint
involv
read
assay
reagent
cost
routin
matter
use
either
immunofluoresc
situ
hybrid
assay
adenoviru
detect
would
result
obviou
save
time
compar
cytopathogen
effort
reduc
incub
period
either
two
assay
h
period
h
unsuccess
hand
caus
lack
success
due
reduc
format
within
shorter
time
period
viral
capsid
protein
nucleic
acid
within
infect
cell
optimum
choic
detect
adenovirus
may
howev
still
rest
use
eytopathogen
assay
perform
highli
sensit
cell
line
